Myxoid adrenal cortical carcinoma, a rare type of adrenal cortical cancer. A case report

Cover Page

Cite item

Abstract

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex with aggressive clinical behavior and an unfavorable prognosis. Its estimated annual incidence is 0.5 to 2 cases per 1,000 000. The unfavorable prognostic factors include its rare variants, such as myxoid ACC. This ACC type was first reported as early as in 1979; however, its low prevalence hinders any reliable assessment of its prognostic value. Few published data indicate more than 2-fold lower median survival of patients with myxoid ACC, compared to that in classical ACC. Here we present a rare clinical case of myxoid ACC in a 56-year old woman with Cushing's syndrome, invasion of the adjacent tissues and organ by the time of diagnosis, rapid progression of the disease with fatal outcome. We discuss the variations of the myxoid component, associated with different cellular growth patterns in ACC. This clinical case demonstrates the aggressive course of myxoid ACC type, compared to the classical one, and is aimed at drawing the attention of various medical specialists to rare ACC variants.

About the authors

P. A. Korosteleva

Moscow Regional Research and Clinical Institute (MONIKI)

Author for correspondence.
Email: polina.lopatieva@gmail.com

Polina А. Korosteleva - MD, Department of Pathological Anatomy1

61/2-13 Shchepkina ul., Moscow, 129110.

Tel.: +7 (495) 631 74 22.

Russian Federation

A. V. Krivosheev

Moscow Regional Research and Clinical Institute (MONIKI)

Email: doc275@mail.ru
ORCID iD: 0000-0003-3643-6810

Alexey V. Krivosheev - MD, Junior Research Fellow, Department of Endocrine Surgery.

61/2 Shchepkina ul., Moscow, 129110.

Russian Federation

S. V. Vorontsova

Moscow Regional Research and Clinical Institute (MONIKI)

Email: svetlanayud@yandex.ru
ORCID iD: 0000-0003-3584-4345

Svetlana V. Vorontsova - MD, PhD, Department of Diagnostic Radiology.

61/2 Shchepkina ul., Moscow, 129110.

Russian Federation

I. A. Voronkova

Moscow Regional Research and Clinical Institute (MONIKI)

Email: iya-v@yandex.ru
ORCID iD: 0000-0001-6687-3240

Iya A. Voronkova - MD, PhD, Department of Pathological Anatomy.

61/2 Shchepkina ul., Moscow, 129110.

Russian Federation

T. A. Britvin

Moscow Regional Research and Clinical Institute (MONIKI)

Email: t.britvin@gmail.com
ORCID iD: 0000-0001-6160-1342

Timur A. Britvin - MD, PhD, Chief Research Fellow, Division of Surgery.

61/2 Shchepkina ul., Moscow, 129110.

Russian Federation

Yu. G. Krivosheeva

Moscow Regional Research and Clinical Institute (MONIKI)

Email: yulya.k.89@inbox.ru
ORCID iD: 0000-0002-2061-5235

Yulia G. Krivosheeva - MD, Department of Therapeutic Endocrinology, Division of Therapy.

61/2 Shchepkina ul., Moscow, 129110.

Russian Federation

References

  1. Lam AK. Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours. Endocr Pathol. 2017;28(3):213-27. doi: 10.1007/s12022-017-9484-5.
  2. Giordano TJ, Chrousos GP, de Krijger RR, Gill AM, Kawashima A, Koch CA, Medeiros LJ, Merino MJ, Papathomas TG, Papotti M, Sasa-no HR, Weiss LM. Adrenal cortical carcinoma. In: Lloyd RV, Osamura RY, Kloppel G, Rosai J, editors. WHO classification of tumours of endocrine organs. 4th edition. Vol. 10. Lyon: IARC; 2017. р. 163-9.
  3. Dworakowska D, Drabarek A, Wenzel I, Babins-ka A, Swiqtkowska-Stodulska R, Sworczak K. Adrenocortical cancer (ACC) - literature overview and own experience. Endokrynol Pol. 2014;65(6):492-502. doi: 10.5603/EP.2014.0069.
  4. Papotti M, Libe R, Duregon E, Volante M, Bertherat J, Tissier F. The Weiss score and beyond - histopathology for adrenocortical carcinoma. Horm Cancer. 2011;2(6):333-40. doi: 10.1007/s12672-011-0088-0.
  5. Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol. 1984;8(3):163-9. doi: 10.1097/00000478198403000-00001.
  6. Lau SK, Weiss LM. The Weiss system for evaluating adrenocortical neoplasms: 25 years later. Hum Pathol. 2009;40(6):757-68. doi: 10.1016/j.humpath.2009.03.010.
  7. Lucon AM, Pereira MA, Mendonca BB, Zerbi-ni MC, Saldanha LB, Arap S. Adrenocortical tumors: results of treatment and study of Weiss's score as a prognostic factor. Rev Hosp Clin Fac Med Sao Paulo. 2002;57(6):251-6. doi: 10.1590/s0041-87812002000600002.
  8. Morimoto R, Satoh F, Murakami O, Suzuki T, Abe T, Tanemoto M, Abe M, Uruno A, Ishi-doya S, Arai Y, Takahashi K, Sasano H, Ito S. Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/ MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas. Endocr J. 2008;55(1):49-55. doi: 10.1507/endocrj.k07-079.
  9. Papathomas TG, Pucci E, Giordano TJ, Lu H, Duregon E, Volante M, Papotti M, Lloyd RV, Tischler AS, van Nederveen FH, Nose V, Erickson L, Mete O, Asa SL, Turchini J, Gill AJ, Ma-tias-Guiu X, Skordilis K, Stephenson TJ, Tissier F, Feelders RA, Smid M, Nigg A, Korpershoek E, van der Spek PJ, Dinjens WN, Stubbs AP, de Krijger RR. An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma. Am J Surg Pathol. 2016;40(4):569-76. doi: 10.1097/PAS.0000000000000574.
  10. Tang CK, Harriman BB, Toker C. Myxoid adrenal cortical carcinoma: a light and electron microscopic study. Arch Pathol Lab Med. 1979;103(12):635-8.
  11. Sung TY, Choi YM, Kim WG, Lee YM, Kim TY, Shong YK, Kim WB, Song DE. Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center. J Korean Med Sci. 2017;32(5):764-71. doi: 10.3346/jkms.2017.32.5.764.
  12. Libe R, Borget I, Ronchi CL, Zaggia B, Kroiss M, Kerkhofs T, Bertherat J, Volante M, Quinkler M, Chabre O, Bala M, Tabarin A, Beuschlein F, Vezzosi D, Deutschbein T, Borson-Chazot F Hermsen I, Stell A, Fottner C, Leboulleux S, Hahner S, Mannelli M, Berruti A, Haak H, Ter-zolo M, Fassnacht M, Baudin E; ENSAT network. Prognostic factors in stage III—IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. Ann Oncol. 2015;26(10):2119-25. doi: 10.1093/annonc/mdv329.
  13. Lughezzani G, Sun M, Perrotte P, Jeldres C, Alasker A, Isbarn H, Budaus L, Shariat SF, Guaz-zoni G, Montorsi F, Karakiewicz PI. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation. Eur J Cancer. 2010;46(4):713-9. doi: 10.1016/j.ejca.2009.12.007.
  14. Papotti M, Volante M, Duregon E, Delsed-ime L, Terzolo M, Berruti A, Rosai J. Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior. Am J Surg Pathol. 2010;34(7):973-83. doi: 10.1097/PAS.0b013e3181e2b726.
  15. Berruti A, Fassnacht M, Haak H, Else T, Baudin E, Sperone P, Kroiss M, Kerkhofs T, Williams AR, Ardito A, Leboulleux S, Volante M, Deutsch-bein T, Feelders R, Ronchi C, Grisanti S, Gelder-blom H, Porpiglia F, Papotti M, Hammer GD, Allolio B, Terzolo M. Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. Eur Urol. 2014;65(4):832-8. doi: 10.1016/j.euru-ro.2013.11.006.
  16. Adrenal cortical carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. WHO classification of tumors: pathology and genetics of tumors of endocrine organs. 3rd edition. Vol. 8. Lyon: IARC; 2004. 320 p.
  17. Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M, Worden FP. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer. 2005;12(3):667-80. doi: 10.1677/erc.1.01029.

Supplementary files

There are no supplementary files to display.


Copyright (c) 2020 Korosteleva P.A., Krivosheev A.V., Vorontsova S.V., Voronkova I.A., Britvin T.A., Krivosheeva Y.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies